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Abstract
The impact of a positive fluid balance on morbidity and mortality has been well established. However, little is known 
about how to monitor fluid status and fluid overload. 
This narrative review summarises the recent literature and discusses the different parameters related to bio-electrical 
impedance analysis (BIA) and how they might be used to guide fluid management in critically ill patients. Definitions 
are listed for the different parameters that can be obtained with BIA; these include among others total body water 
(TBW), intracellular water (ICW), extracellular water (ECW), ECW/ICW ratio and volume excess (VE). BIA allows cal-
culation of body composition and volumes by means of a current going through the body considered as a cylinder. 
Reproducible measurements can be obtained with tetrapolar electrodes with two current and two detection elec-
trodes placed on hands and feet. Modern devices also apply multiple frequencies, further improving the accuracy 
and reproducibility of the results. Some pitfalls and conditions are discussed that need to be taken into account for 
correct BIA interpretation. Although BIA is a simple, noninvasive, rapid, portable, reproducible, and convenient me-
thod of measuring body composition and fluid distribution with fewer physical demands than other techniques, it 
is still unclear whether it is sufficiently accurate for clinical use in critically ill patients. However, the potential clinical 
applications are numerous. 
An overview regarding the use of BIA parameters in critically ill patients is given, based on the available literature. BIA 
seems a promising tool if performed correctly. It is non-invasive and relatively inexpensive and can be performed at 
bedside, and it does not expose to ionising radiation. Modern devices have very limited between-observer variations, 
but BIA parameters are population-specific and one must be aware of clinical situations that may interfere with the 
measurement such as visible oedema, nutritional status, or fluid and salt administration. BIA can help guide fluid 
management, resuscitation and de-resuscitation. The latter is especially important in patients not progressing spon-
taneously from the Ebb to the Flow phase of shock. More research is needed in critically ill patients before widespread 
use of BIA can be suggested in this patient population.
Key words: fluid resuscitation, fluid management, fluid balance, monitoring, BIA, bio-electrical impedance analysis, 
deresuscitation
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The impact of a positive fluid balance on morbidity and 
mortality has been well established [1−4]. However, little is 
known about how to monitor fluid status and fluid overload. 
The human body consists of around 60% water, 18% protein, 
16% fat, and 6% minerals. The tissue water content varies 
from 20% (fat tissue and bones) up to 85% (kidneys, liver, 
blood). Children may have more water (70%) than adults 
(50−55%), while women usually have less water and more 
fat compared to men [5]. 
Bio-electrical impedance analysis (BIA) measures whole 
body (or regional or segmental) impedance, phase angle, 
resistance, reactance and capacitance, by means of an elec-
tric current transmitted at different frequencies [5, 6]. New 
techniques allow measurement of total body water (TBW) 
with separation into extracellular and intracellular water 
(ICW) [7]. Data suggests that BIA may provide useful in-
formation not only in different well-established patient 
groups (like dialysis, AIDS, malnutrition) but also in critically 
ill patients with burns, trauma and sepsis undergoing fluid 
resuscitation [8−15]. 
This narrative review summarises the recent literature 
and discusses the different parameters related to bio-elec-
trical impedance analysis, focusing on their use in guiding 
fluid management (resuscitation and deresuscitation) in 
critically ill patients.
DEFINITIONS
Definitions of electrical quantities generated by BIA are 
reviewed here. More detailed information can be found 
in some reviews on this topic together with the National 
Institute of Health (NIH) health technology assessment [5, 
16]. The European Society of Enteral and Parenteral Nutri-
tion (ESPEN) also recently published concise guidelines on 
bioelectrical impedance analysis [17, 18]. 
Capacitance (C): in electrical terms, is the storage of 
an electrical charge by a condenser for a short moment in 
time. Capacitance measurements in a living substance are 
an indicator of healthy cell membrane. Depending on the 
health and the number of cells, the electrical capacitance 
will increase or decrease. 
Reactance (X): the opposition of a circuit element to 
a change of electric current or voltage, due to that element’s 
inductance or capacitance (related to cell mass). 
Resistance (R): the resistance of an electrical conductor is 
the opposition to the passage of an electric current through 
that conductor (inversely related to the water content). 
Insulator: tissue that consists of cells that are not con-
ducting electrical signals, e.g. fat cells where resistance is 
high and impedance is high. 
Conductor: tissue that allows electricity to flow easily, 
e.g. muscles, water content, where resistance is low and 
impedance is low. 
Impedance (Z): represents the ratio between insulation 
tissue and conductive tissue.
BIA PRINCIPLE
BIA allows the calculation of body composition and 
volumes by means of an electric current going through 
the body considered as a cylinder (Fig. 1). Detailed descrip-
tions of the principles can be found elsewhere [5, 16−18]. 
In order to obtain reproducible measurements, BIA has to 
make five assumptions: 1) the human body can be con-
sidered as a cylinder; 2) it consists in fact of five smaller 
cylinders (one central cylinder, two arms and two legs); 3) 
body composition is assumed to be homogenous; 4) with 
absence of individual variation; and 5) without impact of 
environment (temperature, stress, infusions). This of course 
only holds true in an ideal situation that can differ from real 
life conditions, especially in the critically ill. These condi-
tions include significant body asymmetry as in amputations, 
unilateral hemiparesis, and neuromuscular conditions that 
produce localised changes in perfusion or tissue atrophy 
[5]. Furthermore, there may be differences between men 
Cylinder
Lenght
Current Cross
sectional
area
Figure 1. BIA principle. When electric current goes through a cylinder 
shaped body, the impedance (Z) is related to the length (L) and 
specific resistivity (ρ) of the tissue and inversely related to the cross-
sectional area (A) of the cylinder. The volume of a cylinder (V) can be 
calculated as L multiplied by A
How does bioelectrical impedance analysis calculate volumes?
Z = ρ × 
L
A
Z = ρ × 
L
A
× 
L
L
Z = ρ × 
L2
V
Extrapolated to a patient, L stands for the height (in cm) so that the 
body composition and volume (V) can be calculated as follows:
V = ρ × 
L2
Z
where V = ρ × 
L2
Z
 corresponds to the impedance index that can be 
calculated with bioelectrical impedance analysis
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and women and old and young with regard to evolution of 
the cylindrical shape. 
Therefore, in order to obtain a good BIA measurement, 
five factors are indispensable: impedance value, height, 
weight, gender, and age. Of these five, gender and age 
are the most important in obtaining the highest level of 
accuracy. Furthermore, body composition is based on ge-
netic (25%), cultural (30%) and non-transmissible (45%) 
factors. Human body composition measurements can be 
performed at five levels: atomic (oxygen, carbon hydrogen, 
nitrogen), molecular (protein, carbohydrate, lipid, minerals, 
water), cellular (fat cells, body cells, intra- and extracellular 
fluids, organic and inorganic extracellular solids), tissue (adi-
pose, muscle, bone, blood) and whole body level. BIA allows 
a four compartment body composition analysis dividing 
the body into fat, water, mineral, and protein components 
(Fig. 2)[16]. 
BIA MEASUREMENT
Reproducible measurements can be obtained with 
tetrapolar electrodes with two current electrodes (to drive 
electricity into the human body) and two detection elec-
trodes (to detect impedance) placed on hands and feet. 
Tetrapolar techniques provide more reproducible results 
[17, 18]. Although some data is available on segmental 
measurements of the arm, leg, and trunk, segmental BIA 
should at present be considered as purely experimental 
and more information is needed to determine whether ad-
ditional electrode placement sites offer improvement over 
standard BIA techniques [5, 19]. Modern devices also apply 
multiple frequencies, further improving the accuracy and 
reproducibility of the results. The frequency is the number 
of repetitions per second of a complete electric waveform 
(one repetition per second is 1 Hz) [6, 7, 20]. A current with 
a frequency below 100 Hz will not pass the cell membranes 
and as such will measure only extracellular water (ECW). 
Current frequencies above 100 Hz will go through cells and 
measure total body water (TBW). The intracellular water 
(ICW) can then be calculated as TBW minus ECW (Fig. 3A). 
When an electric current passes a cell membrane, a time 
delay occurs, expressed as phase angle. The phase angle is 
the relationship between resistance and reactance. A phase 
angle of 0 degrees is an indicator of the absence of cell 
membranes, whereas 90 degrees represents a capacitive 
circuit which consists of only membranes with no fluid. Cell 
membranes cause time delays compared to time taken pass-
ing through extracellular water. The greater the number of 
cell membranes the signal has to pass through, the longer 
the time delay. The higher the phase angle, the greater the 
proportion of ICW compared to ECW [16]. So a high phase 
angle is consistent with high reactance and a large amount 
of waste cell membrane and body cell mass (BCM) as seen 
ICW
23.4 (Optimal)
(22.9–25.0)
ECW
14.8 (Optimal)
(13.2–15.3)
BW
Standard weight 63.3 (Optimal)
(57.2–69.9)
LBM
53.1 (Optimal)
(50.7–54.2)
SLM
49.1 (Optimal)
(47.1–50.2)
SMM
24.0 (Optimal)
(22.0–27.0)
Protein
10.9 (Optimal)
(10.1–11.4)
Minerals
4 (Over)
(3.6–3.8)
Body Fat
15.2 (Over)
(9.5–12.7)
TBW
38.2 (Optimal)
(36.6–38.9)
Figure 2. Four compartment body composition analysis with BIA
ICW: Intracellular water (body water that exists inside the cell membrane)
ECW: Extracellular water (body water that exists outside the cell membrane; extracellular can be further subdivided 
 into interstitial, lymphatic, trans-cellular fluid and blood)
TBW: Total body water = ICW + ECW (body water that exists in- and outside of cell membrane)
SLM: Soft lean mass = total body water + protein (skeletal and smooth muscle maintaining body function)
SMM: Skeletal muscle mass
LBM:  Lean body mass = SLM + minerals
BW: Body weight = LBM + body fat
The values in between () are the range of standard body composing constituents. Units are expressed in Litres
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in healthy individuals, whereas (critically ill) patients tend 
to have a low phase angle (Fig. 3B) [12, 21]. 
Bio-electrical impedance vector analysis (BIVA) repre-
sents the values reactance and resistance in an X-Y plot ref-
erencing to a healthy population; as such one can appreciate 
the evolution of fluid and nutritional status in patients over 
time (Figure 4). Recent studies have shown a reasonable 
correlation between BI(V)A parameters and central venous 
pressure (CVP), brain natriuretic peptide (BNP) and fluid 
balance [9, 22, 23]. However, in a study on 43 mechanically 
ventilated patients, House et al. came to the conclusion that 
BIVA and CVP were not helpful, whereas BNP was the best 
predictor for poor oxygenation status [22].
BIA PARAMETERS
Table 1 lists the different parameters that can be ob-
tained with BIA. Absolute measurements of impedance, 
reactance, resistance and capacitance have been highly 
correlated to changes in the human body and have been 
shown to be good prognostic indicators [24]. Under- and 
overestimation of dry weight is important and has been 
shown to impair the survival and quality of life of haemodi-
alysis or peritoneal dialysis patients [25, 26]. Body composi-
tion and nutritional assessment of children and adults in 
clinical settings is important in order to identify potential 
causes of inadequate nutrition status, including the risk of 
malnutrition. Performing nutritional assessments in dis-
eased patients enables doctors to identify related disorders 
and to monitor the effects of treatment [27]. The glomerular 
Extracellular pathway
Intracellular pathway
R2C C
R1
R
Increasing
frequency
X
0 = –tan–1(X/R)
Z = (X2  + R2 )1/2
A
B
Figure 3. BIA principles. A — biological tissues act as conductors 
or insulators and the flow of current through the body will follow 
the path of least Resistance (R). Fat Free Mass (FFM) contains large 
amounts of water and electrolytes and therefore is a better conductor 
of electrical current than fat and bone, which are poor conductors as 
they contain low amounts of fluid and conducting electrolytes. The 
cell membrane of a body consists of a layer of non-conductive lipid 
(fat, oils and other lipid like substance) material sandwiched between 
two layers of conductive protein molecules. Cell membranes become 
reactive elements behaving as capacitors (C) when electrical current 
is applied; B — with BIA the Phase angle (θ), the Reactance (X) 
and the Resistance (R) are measured. Normal Phase angle is 4−15°. 
Adapted from Foster and Lukaski [16]
Figure 4. Bio-electrical impedance vector analysis (BIVA). Illustrative case of a 56-year-old man admitted to 
ICU after bowel perforation and four quadrant peritonitis. Bio-electrical impedance vector analysis (BIVA) plot 
of individual BIA measurements with Resistance (R) on X-axis and Reactance (X) on Y-axis; the centre point 
with coordinates (0,0) refers to the healthy population. Points 1 to 5 show evolution of obtained values from 
baseline to recovery of the acute illness. (BCM: body cell mass)
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filtration rate (rate at which waste is removed from our kid-
neys) is an important indicator of kidney function. Studies 
have shown a good correlation between BIA and other 
techniques in the estimation of GFR, avoiding the need for 
24 hour urine collection (gold standard creatinine clearance) 
or using other calculations (Cockroft-Gault, MDRD (modifi-
cation of diet in renal disease), or CKD-EPI (Chronic Kidney 
Disease Epidemiology Collaboration) formula) [28, 29]. BIA 
can obtain information on mineral (bone, soft tissue) and 
protein content of the body. In some patients, assessment 
of the loss of minerals can be very important. Glycogen 
mass is the primary storage form of carbohydrates found in 
the cytoplasma of most cells. Intracellular and extracellular 
body fluid status in both healthy and diseased patients is of 
significant importance. Extracellular Water (ECW) increases 
in different diseases and oedema is the most common sign 
of ECW expansion. Monitoring these changes in patients 
can provide us with detailed information and understand-
ing of changes as a result of disease. Body cell mass (BCM) 
is an accurate method of establishing a healthy subject’s 
nutritional status or a patient’s degree of malnutrition. BCM 
is used for calculation of energy expenditure and other 
metabolic measures.
vALIDATION
Although BIA is a simple, noninvasive, rapid, portable, 
reproducible, and convenient method of measuring body 
composition and fluid distribution with fewer physical de-
mands (than anthropometric techniques for instance), it is 
still unclear whether it is sufficiently accurate for clinical use 
in critically ill patients [30]. BIA measures TBW and as such it 
needs to be validated through comparison with other means 
of determining TBW or methods (such as densitometry) used 
to derive the components of the two-compartment model 
of the body composition, namely fat free mass, and body fat. 
Because BIA disproportionately considers the extremities, 
the relationship between impedance and TBW can only be 
empirical. As explained in the NIH health technology assess-
ment, this places an important constraint on the derived 
value: TBW must be altered in the torso and the extremities 
in a fixed relationship in health and disease in order to retain 
predictive value [5]. This relationship probably exists in most 
normal subjects and in those with mild disease perturba-
tions such as mild-to-moderate obesity and other chronic 
illnesses not producing local fluid accumulation.
The gold standard techniques for measuring body com-
position and TBW are isotope dilution (labelled deuterium), 
followed by dual energy X-ray absorptiometry (DEXA), un-
derwater weighing, and air-displacement plethysmography. 
Abdominal and visceral fat can also be measured with com-
puted tomography (CT) and magnetic resonance imaging 
(MRI). These techniques require special facilities and cannot 
be used for daily bedside measurements. Previous studies 
showed varying results and in some cases BIA could not 
provide additional information [6, 19, 31, 32]. Total body 
potassium (TBK) has been found to be linearly correlated 
with body cell mass (BCM) [31]. However, laboratory tech-
niques such as total body potassium (40K and 42K) are not 
practical for everyday bedside monitoring. Portable meth-
ods consist of infrared analysis, skinfold caliper measure-
ment, and dual contact BIA. Tetrapolar BIA falls in between 
basic and advanced methods. Different studies comparing 
BIA to DEXA have shown good correlation [19]. For clinical 
purposes, two devices are available to be used in (critically 
Table 1. Different parameters that can be obtained with BIA
abSoLUte MeaSUreMentS
•	 Impedance (Z)
•	 Phase Angle (θ)
•	 Resistance (R)
•	 Reactance (X)
•	 Capacitance (C)
drY Weight
•	 Dry Weight
bodY coMPoSition
•	 Fat%
•	 Fat Mass
•	 Fat Free Mass (FFM, L or %)
•	 Fat Free Mass Hydration (FFMH,%)
•	 Body Volume
•	 Body Density
•	 Body Mass Index (BMI)
•	 Resting Metabolic Rate
•	 Target Fat (min/max)%
•	 Target Weight (min/max)
•	 Target Water (min/max)%
KidneY fUnction
•	 Glomerular Filtration Rate (GFR)
MineraLS and Protein
•	 Total Body Potassium (TBK)
•	 Total Body Calcium
•	 Protein Mass
•	 Mineral Mass
gLYcogen
•	 Glycogen Mass
fLUid StatUS
•	 Extracellular Fluid
•	 Intracellular Water Volume (ICW, L or %)
•	 Extracellular Water Volume (ECW, L or %)
•	 Total Body Water Volume (TBW, L or %)
•	 Extracellular Mass
•	 Extracellular Solids
•	 Extracellular/Intracellular Water, ECW/ICW ratio
•	 Extracellular Water/Total Body Water
•	 Intracellular Water/Total Body Water
•	 Interstitial-Fluid Extravascular
•	 Plasma-Fluid (Intravascular)
•	 Intracellular Water/Total Body Water
•	 Body Cell Mass (BCM)
•	 Muscle Mass
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ill) patients: the Fresenius Medical Care Body Composition 
Monitor (BCM) (Fresenius Medical Care, Bad Homburg, Ger-
many) (http://www.bcm-fresenius.com/index.html), and the 
Maltron BioScan 920 (Maltron International Ltd, Rayleigh, 
UK) (http://www.maltronint.com/products/bioscan920-2S.
php). However, no head-to-head comparison has been per-
formed in a large sample of critically ill patients. 
CLINICAL APPLICATIONS
nUtritional assessment
As suggested by ESPEN: “BIA is an important clinical tool 
for evaluating the metabolic status of intensive care unit (ICU) 
patients. It is inexpensive and noninvasive, and it provides 
useful information concerning altered body composition and 
membrane potential at the tissue level measured by phase 
angle, as well as fluid imbalance” [17, 18]. Disease states 
can have a profound impact on body composition as listed 
in Table 2. As a consequence, from a theoretical point of 
view, the clinical applications for BIA could be numerous: 
AIDS, muscle wasting, anorexia, postmenopausal women, 
obesity, pregnancy, Crohn’s disease, cystic fibrosis, diabe-
tes, paediatric diseases, enteral and parenteral nutrition, 
elderly, rheumatoid disease, tropical disease, sepsis and 
septic shock. Studies have shown that fat-free mass (FFM) 
was lower and fat mass was higher in, respectively, acutely 
ill and chronically ill patients than in controls [21]. Sarcope-
nia is the backdrop against which the drama of disease is 
played out, a body already depleted of protein because of 
ageing or starvation is less able to withstand the protein 
catabolism that comes with acute illness or inadequate 
protein intake [33]. BIA may be clinically useful for demon-
strating sarcopenic obesity in women at normal BMI, with 
additional studies necessary to determine the metabolic 
reasons underlying this change in body composition [34]. 
BIA can be helpful in burn patients, cardiovascular diseases, 
peripheral oedema, gastroenteritis, haemodialysis, con-
tinuous veno-venous haemofiltration (CVVH), peritoneal 
dialysis, liver disease, second and third spacing (segmental 
analysis), lung disease (like ARDS with capillary leak), mal-
nutrition, bariatric surgery, postoperative fluid status, renal 
failure, and stroke.
chronic kidney disease
BIA can detect changes in body composition even in 
the early stages of kidney disease and in patients with car-
dio-renal syndromes, showing lower resistance, abnormal 
impedance vectors, reduced phase angle, and higher TBW 
together with a lower BCM. Importantly, patients do need 
to have overt signs of overhydration or malnutrition for BIA 
to detect these alterations [35, 36]. These changes in body 
composition continue during the entire spectrum of chronic 
kidney disease, being most evident in end-stage renal dis-
ease (ESRD). Compared to the National Health and Nutrition 
Examination Survey (NHANES) III population, ESRD patients 
(chronic maintenance dialysis patients) had lower resistance, 
reactance, phase angle, intracellular water and body cell 
mass values, in contrast to a 17% higher extracellular water 
value [37]. In chronic haemodialysis patients, multifrequency 
whole body BIA can give an objective measure of fluid and 
nutritional status, calculating overhydration within one to 
two litres [38]. It can therefore provide an appropriate and 
noninvasive method for the determination of dry weight 
(especially compared to other methods such as deuterium 
dilution technique, anthropometry, or the Watson equation) 
[39]. Using BIA as a guide to achieving dry weight results 
in an improved fluid status and the control of blood pres-
sure [40]. In the long term, this means a greater decline in 
arterial stiffness, (chronic) fluid overload and systolic blood 
pressure and even all-cause mortality [41]. In peritoneal 
dialysis patients, who often have a significant residual kid-
Table 2. Effects of disease states on body composition
impact of illness on tissue impact of illness on fluid status
•	 Loss of or low body fat 
•	 Excessive weight gain 
•	 Loss of body weight 
•	 Loss of fat free mass 
•	 Low muscle tissue mass
•	 Loss of or low bone mineral 
•	 Loss of body cell mass 
•	 Malnourishment
•	 Increased catabolism
•	 Delayed anabolism
•	 High body density 
•	 Clinical muscle wasting (cachexia wasting syndrome, 
sarcopenia) 
•	 Higher bone mass and mineral density 
•	 Reduced lean trunk mass 
•	 Fluid imbalance 
•	 Positive daily fluid balance 
•	 Positive cumulative fluid balance 
•	 Peripheral oedema 
•	 Altered fluid status — changes in total body water, extracellular and 
intracellular fluids 
•	 Increase or decrease in intracellular water (decreased body cell mass and 
total body potassium) 
•	 Increase in extracellular water (oedema)
•	 Plasma volume increases and fluid accumulates in the lungs, abdominal 
organs and peripheral tissues 
•	 Changes in water, mineral and protein contents 
•	 Increase in ECW/ICW ratio
•	 Increase in total body water
•	 Change in fat free mass hydration
•	 Variations in TBW-to-FFM ratio
•	 Variations in impedance-to-TBW ratio
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ney function, BIA-guided fluid management with measure-
ments performed after draining the intraperitoneal cavity 
[42] can help restore diuresis in underhydrated patients 
and improve tension and weight control in overhydrated 
patients [8, 43].
critical care
Many conditions exist in critical illness (ascites, anasarca, 
severe peripheral oedema, pleural effusions, the massively 
overhydrated patient, as well as other clinical conditions in 
which there are severe disturbances in water and electro-
lyte distribution) where conventional BIA may be a poor 
measure of TBW [17, 18]. Therefore, for the time being BIA 
can only be considered as a research tool in critically ill 
patients because the TBW-to-FFM ratio is variable and the 
body impedance-to-TBW ratio may often vary during the 
above-cited conditions [5, 17, 18].
It is important for the clinician to be aware that the nor-
mal ECW/ICW ratio is less than 1. An increase in ICW is seen 
in patients with heart failure, liver cirrhosis and chronic renal 
failure (especially early stage). A decrease in ICW is generally 
related to osmotic factors, while increases in ECW are mostly 
due to a shift from intra- to extracellular space as seen with 
second (interstitial) and third space (ascites, pleural effusion) 
oedema, in the late stages of the above-cited conditions 
(heart, or liver or kidney failure). 
Critically ill patients, especially those with sepsis or se-
vere sepsis, are prone to develop changes in body fluid 
distribution with migration of fluid from the intravascular 
to the extravascular space. Furthermore, the systemic in-
flammatory response produces changes between the FFM 
and TBW distribution [44]. In addition, oxidative stress and 
production of reactive oxygen species is associated with 
damage of the cell membrane and loss of cell wall integrity, 
which may result in a drop in the phase angle, as discussed 
above. Raw impedance data can provide information on 
hydration and cell mass integrity [45].
Plank found that although changes in TBW were similar, 
patients with peritonitis and sepsis (n = 12) had higher ECW 
values compared to those with blunt trauma (n = 18) [11]. 
In a study on the use of continuous veno-venous haemofil-
tration to adjust fluid volume excess in 30 septic shock pa-
tients with acute kidney injury (AKI), Dabrowski et al. found 
a sustained increase in TBW, ECW (Fig. 5A) and ECW/ICW 
ratio (Fig. 5B) in nonsurvivors [46]. Volume excess (VE) was 
also associated with increased intra-abdominal pressure 
(IAP) and worse outcomes. The use of CVVH with net ul-
trafiltration (UF) successfully reduced IAP, TBW, ECW, and 
ICW in those patients who survived 96 h of CVVH. A similar 
study in 68 ICU patients with sepsis (n = 51) compared 
to patients without sepsis (n = 17) showed that ECW and 
FFM hydration were increased in severe sepsis compared 
to sepsis [47]. Raw impedance data analysis showed that 
patients without sepsis had significantly lower resistance 
values (401.1 ± 129.56 Ω vs 490.4 ± 142.06 Ω, P = 0.025) and 
resistance normalised by height than patients with con-
firmed sepsis (241.16 ± 80.3 Ω m-1 vs 293.05 ± 89.35 Ω m-1; 
P = 0.037). Changes in tissue physiology and integrity during 
sepsis may produce changes in electrical properties; as such, 
the use of raw data obtained with BIA seems promising. 
Indeed, raw data is not influenced by assumptions that 
can affect body composition results, and BIVA provides 
information on tissue hydration and BCM independent of 
regression equations, even in overhydrated patients [24]. 
The study by Slotwinski showed that patients with sepsis 
had significantly higher raw impedance (566 ± 98.66 Ω vs 
423.86 ± 149.7 Ω; P = 0.0003) and resistance normalised 
BL
0.2
0.4
0.6
0.8
1.0
0
1.2
Day 1 Day 2 Day 3
survivor nonsurvivor
1.4
*
*
* *
BL
5
10
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20
25
0
30
Day 1 Day 2 Day 3
survivor nonsurvivor
35
*
*
A
B
Figure 5. Day-by-day evolution of BIA parameters in survivors vs 
nonsurvivors; A — day-by-day evolution in ECW between survivors 
and nonsurvivors; B — day-by-day evolution in ECW/ICW ratio 
between survivors and nonsurvivors (normal ratio, < 1, as indicated 
by the dotted line). Adapted from Dabrowski et al. [46]; * denotes 
P-value < 0.05; BL — baseline
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by height (336.69 ± 66.9 Ω m-1 vs 259.94 ± 90.9 Ω m-1; 
P = 0.00165) than those with severe sepsis [47]. However, the 
% ECW was lower in sepsis vs severe sepsis (45.95 ± 2.97% 
vs 49.2 ± 6.11%; P = 0.026). The sepsis population was po-
sitioned mainly on the lower left side of the BIVA tolerance 
ellipses, characterised by fluid retention and drop in BCM 
[24]. In the abovementioned study, 49% of sepsis cases were 
located above the 50th percentile, suggesting fluid accumu-
lation as shown in Figure 6 [47]. The lower mean phase angle 
of the patients with sepsis being above the 50th percentile 
in the study by Slotwinski could be related to a low body 
cell mass and high ECW/ICW ratio, as observed by other 
investigators [48]. Piccoli et al. [49] previously found that 
cardiac patients with dyspnoea falling on the lower side of 
the 50% tolerance ellipse presented with increasing fluid 
volume and CVP. A retrospective study comparing BIA data 
from critically ill patients (n = 15) with healthy volunteers 
(n = 25) showed significant differences in body water com-
position between patients and healthy individuals [50]. In 
this study, patients had higher values for TBW (45 ± 7.7 vs 
38 ± 9.7 L, P = 0.01), ECW (24.1 ± 5.4 vs 16.9 ± 5.3 L, P < 0.0001) 
and ECW/ICW ratio (1.2 ± 0.2 vs 0.8 ± 0.2, P < 0.0001) while 
ICW was lower 20.9 ± 3.8 vs 21.2 ± 5 L, P = NS) (Fig. 7) [50]. 
Patients had a VE of 7.8 ± 5.7 vs −0.2 ± 0.6 L in healthy vol-
unteers (P < 0.0001). Patients also had a significantly lower 
phase angle (at 100 kHz) compared to healthy individuals, 
respectively 8.7 ± 2.8 vs 10.4 ± 1 (P = 0.008).
Figure 6. Bioelectrical impedance vector analysis (BIVA) showing patients with sepsis plotted on three 
tolerance ellipses. Resistance (R) on X-axis and Reactance (X) on Y-axis; the centre point with coordinates 
(0.0) refers to the healthy population. About 49% of sepsis cases were located above the 50th percentile, 
suggesting fluid accumulation (within grey shaded square), see text for explanation. Adapted from 
Slotwinski et al. [47]
TBW
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Figure 7. Bar graph showing mean values for total body water (TBW), 
intracellular water (ICW) and extracellular water (ECW) in 15 ICU 
patients compared to 25 healthy volunteers. Adapted from Huygh et 
al. [50]; *denotes P-value < 0.05
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FLUID STATUS ASSESSMENT
Recent studies have shown that a positive daily, or cu-
mulative positive, fluid balance is an independent predictor 
for poor outcome [1−4, 51−53]. It is beyond the scope of 
this review to discuss the pathophysiologic implications of 
fluid overload in detail as this has been discussed previously 
elsewhere [54, 55]. However, BIA parameters like TBW, ICW, 
ECW, ECW/ICW ratio and VE have a clinical potential and 
can easily be used with other indices of capillary leak and 
fluid overload like daily and cumulative fluid balance, body 
weight, serum capillary leak index (CLI = serum C-reactive 
protein (CRP) divided by serum albumin), renal leak index 
(RLI = urinary albumin divided by serum creatinine), serum 
osmolality and colloid oncotic pressure, extravascular lung 
water and pulmonary vascular permeability index (as can be 
obtained with transpulmonary thermodilution), serum total 
protein, albumin and haemoglobin levels (as measured 
for haemoconcentration vs haemodilution) to name just 
a few [56]. 
BIA PITFALLS AND LIMITATIONS  
IN CLINICAL PRACTICE 
Pitfalls one has to take into account during BIA measure-
ment are changing posture (the best position being supine), 
incorrect position of arms (should be next to body), incorrect 
contact with the electrodes, and contact with another per-
son or object during measurement. Other factors that may 
interfere with BIA measurements that are currently not yet 
well understood are: infusions with large amounts of normal 
saline, peripheral oedema and overhydration (a frequent 
observation in critically ill patients), changes in ambient air 
and skin temperature or fever, sweating, nutrition and oral 
feeding, nutritional status, changes in Na and K content, 
a body mass index (BMI) > 34 kg m-2, specific conductance 
of hospital bed, etc. It is wise to advise anyone with a (tem-
porary) pacemaker or an implanted defibrillator to avoid 
BIA evaluation until this issue has been reviewed, because 
even small currents could potentially provoke an incorrect 
defibrillator response [5]. 
Whole-body bioimpedance analysis measures the bio-
electrical properties between the wrist and the ankle under 
the assumption of a steady fluid distribution. This configu-
ration forces the division of the body on three electrical 
independent segments with different cross-sectional areas 
and lengths: the arm, the trunk, and the leg. The geometrical 
differences of these three segments importantly influence 
their contribution to overall whole-body bioimpedance 
[57]. Moreover, water is not evenly distributed in the hu-
man body. The same volume of extracellular fluid in the 
leg leads to different results in whole-body bioimpedance 
than does a similar volume of extracellular water in the 
trunk. An increase in abdominal water content following as-
cites or intra-peritoneal inflammation significantly disturbs 
whole-body bioimpedance findings. Therefore, whole-body 
bioimpedance is much more sensitive to volume changes 
in the limbs than in the trunk [58]. 
As previously stated, the body position has also 
a significant impact on whole-body bioimpedance find-
ings. Ideally, the measurement of body compartments 
should be performed in the supine position. Trunk eleva-
tion, which is widely used in patients with traumatic brain 
injury, can change body water distribution, reducing 
the credibility of whole-body bioimpedance measure-
ments [59]. 
It is worth noting that an increase in IAP also affects 
whole-body bioimpedance findings. Third or fourth grade 
of intra-abdominal hypertension significantly congest ab-
dominal vessels reducing blood outflow from the limb [60]. 
An increase in intravenous volume and a decrease in venous 
compliance lead to interstitial oedema in the limb, which 
increases the electrical conductivity disturbing whole-body 
bioimpedance findings [61]. Therefore, the credible meas-
urement of body water distribution should always be seen 
in relation to measurement of IAP.
CONCLUSIONS
The recommendations for fluid monitoring can at best 
be described as open for discussion and debate. Any meas-
urement stands or falls on its accuracy and reproducibil-
ity. Nevertheless, bioelectrical impedance analysis seems 
a promising tool if performed correctly. BIA has numerous 
advantages as it is non-invasive and relatively inexpensive 
and can be performed easily at the bedside, while it does not 
expose to ionising radiation as do other techniques. Mod-
ern BIA devices have very limited between-observer vari-
ations. However, BIA parameters are population-specific 
and one must be aware of clinical situations that may in-
terfere with the measurement. BIA allows assessment of 
different parameters related to the patient’s fluid status 
such as TBW, ICW, ECW, ECW/ICW ratio and VE and as such 
it can help guide resuscitation and de-resuscitation (per-
haps something of even greater importance) in patients 
not progressing spontaneously from the Ebb to the Flow 
phase of shock [62]. More research is needed in critically ill 
patients before widespread use of BIA can be suggested in 
this patient population.
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